- Urgent Care Billing Specialists
Urgent Care Medical Billing Services Built for Speed, Volume & Zero-Delay Care
NEO MD delivers urgent-care–dedicated billing, fast claim turnaround, and airtight compliance — all built for the high-volume, quick-cycle nature of urgent care practices.
- 96–98% First-Pass Acceptance
- 18–28% Revenue Increase
- 48-Hour Claim Submission
- Practice Revenue Health Audit
Is Your Pathology Practice
Bleeding Revenue?
Visible Revenue Bleed
Immediate Impact
Surgical Pathology Claims Denied
Specimen count errors on complex cases
Molecular Testing Claims Rejected
Missing medical necessity for genetic testing
Immunohistochemistry Claims Denied
Stain count documentation is insufficient
Flow Cytometry Claims Delayed
Prior authorization failures for cancer diagnostics
Cytology Claims Bundled
When manual screening should've been billed separately
TC/26 Modifier Violations
Wrong component billing on technical vs professional
Invisible Losses
According to CAP and MGMA pathology benchmarking data, practices lose 18%–25% of revenue due to:
Specimen Count Errors
Undercounting separately billable specimens
Molecular Test Bundling
Not billing Tier 1/Tier 2 codes separately
IHC Stain Documentation
Missing individual stain billing
Flow Cytometry Panels
Incomplete component billing
Cytology Screening Codes
Not billing for physician supervision
Decalcification Add-On
Missing 88311 when applicable
Consultation Codes
Not billing 88321-88325 appropriately
Frozen Section Add-Ons
Missing first and additional specimen codes
"You didn't train for 10+ years to fight with insurance companies. But right now, coding errors cost more than a pathologist's salary."
- Industry Problem
Why General Medical Billing Companies Fail Pathology Practices
Pathology billing requires specialty expertise that general billers don’t have.
Specimen counting chaos
Can't determine separately billable specimens
Molecular test blindspot
Don't understand Tier 1/Tier 2 genetic test codes
IHC stain confusion
Can't count and code individual immunostains
Flow cytometry miss
Don't bill multiple marker combinations correctly
Cytology screening errors
Don't capture physician supervision codes
Medical necessity gaps
Can't document molecular test justification
Consultation underbilling
Don't recognize when 88321-88325 apply
TC/26 component mistakes
Misapply modifiers on professional vs technical
Result: 15%–22% denial rates, 45-60 day payment cycles, and constant staff time wasted on resubmissions.
- The NEO MD Difference
The NEO MD Pathology Advantage
Ultra-Specialized Billing Built for Pathology Complexity
Pathology-Certified Coding Teams
- Expert knowledge of surgical pathology code selection (88300-88309)
- Mastery of TC/26 modifier application across all path services
- Molecular pathology coding expertise (81200-81479, 81500 series)
- Immunohistochemistry panel optimization
- Flow cytometry code stacking rules
- Cytopathology component billing (88104-88175)
→ 96-98% first-pass acceptance rate vs 65-75% industry average
LCD Policy Compliance Management
We maintain real-time tracking of:
- MAC-specific LCD policies (Palmetto, NGS, Novitas, CGS, etc.)
- Molecular test coverage determinations
- ICD-10 requirements for specific tests
- Frequency limitations
- Medical necessity documentation standards
- ABN requirements for non-covered tests
→ Zero LCD violation denials through proactive compliance
Molecular Testing Revenue Optimization
Expert handling of:
- NGS panel coding (tier-based selection)
- BRCA testing (81162-81167, 81432-81433)
- Lynch syndrome panels (81292-81294, 81435-81436)
- Pharmacogenomics (81225-81230, 81355)
- Solid tumor panels (81445-81455)
- Hematologic malignancy panels (81450-81455)
- Liquid biopsy/circulating tumor DNA
- Prior authorization for high-cost molecular tests
→ $25,000-$45,000 monthly recovery from molecular test optimization
TC/26 Modifier Precision
We ensure correct modifier application for:
- Professional component only (26)
- Technical component only (TC)
- Global service (no modifier)
- When a split is required vs optional
- Payer-specific TC/26 policies
→ Eliminates payment delays from modifier errors
Surgical Pathology Revenue Maximization
We optimize billing for:
- Specimen type selection (88300-88309 levels)
- Complex specimen examination (88309)
- Decalcification procedures (88311)
- Special stains (88312-88319)
- Immunohistochemistry (88341-88342, 88360-88361)
- Morphometric analysis (88367-88368)
- Tissue preparation and handling (88300 series add-ons)
→ Appropriate reimbursement for complexity and work performed
Cytopathology Component Billing
Expert navigation of:
- Pap smear coding (88142-88175)
- Non-gynecologic cytology (88160-88162)
- FNA interpretation (88172-88173)
- Flow cytometry technical/professional components
- Adequacy determination
- Computer-assisted screening
→ Complete revenue capture on all cytology services
Real-Time Revenue Visibility
We maintain real-time tracking of:
- Daily molecular test claim tracking
- Weekly LCD compliance monitoring
- Monthly financial performance by test category
- Quarterly payer policy update reviews
→ Complete transparency with pathology-specific metrics
Pathology Services We Master
Surgical Pathology
- Gross and microscopic examination (88300-88309)
- Consultation during surgery (88329-88332)
- Pathology consultation (88321-88325)
- Special stains (88312-88319)
- Immunohistochemistry (88341-88342, 88360-88361)
- In situ hybridization (88365, 88366, 88367-88377)
- Morphometric analysis (88367-88368, 88373-88374)
Molecular Pathology
- Tier 1 tests (81161-81383)
- Tier 2 tests (81400-81408)
- Genomic sequencing panels (81410-81471)
- NGS solid tumor panels (81445-81455)
- NGS hematologic panels (81450-81455)
- BRCA analysis (81162-81167, 81432-81433)
- Lynch syndrome (81292-81294, 81435-81436)
- Pharmacogenomics (81225-81230, 81355)
Cytopathology
- Cervical/vaginal cytology (88142-88167)
- Pap smear interpretation (88164-88167)
- Non-gynecologic cytology (88160-88162)
- FNA interpretation (88172-88173)
- Flow cytometry (88184-88189)
Clinical Pathology
- Hematology (85002-85999)
- Coagulation studies (85210-85293)
- Immunology (86000-86849)
- Chemistry (82000-84999)
- Urinalysis (81000-81099)
Transfusion Medicine
- Blood typing (86900-86923)
- Antibody screening (86850-86886)
- Crossmatching (86920-86923)
Microbiology
- Culture and sensitivity (87040-87999)
- Molecular infectious disease (87470-87902)
- Rapid detection tests (87880-87899)
If you provide it in critical care, we bill it correctly—the first time.
Real Results: 8-Pathologist Group Practice (California)
“We had no idea how much money we were leaving on the table with molecular testing. Neo MD’s pathology expertise is extraordinary—they caught coding errors our previous biller made for years. Our molecular test revenue alone increased by $456K annually.”
— Dr. Robert M., Critical Care Medicine
| Metric | Before NEO MD | After NEO MD (90 Days) |
|---|---|---|
| Denial Rate on Molecular Tests | 31% | 3.2% |
| Annual Revenue Loss | $580,000 | Eliminated |
| Molecular Test Revenue Recovered | Missed Revenue | +$38,000 / month |
| Total Revenue Increase | Missed Opportunities | +$68,000 / month ($816K annually) |
| LCD Compliance | Violations Triggering Payer Audits | 99.8% Compliant |
| TC/26 Modifier Accuracy | Missing / Causes Payment Delays | 98%+ |
| NGS Panel Coding Optimization | Under-coded | +$22,000 / month |
| ABN Documentation | No Tracking | 100% Compliant |
| Flow Cytometry Panels | Underbilled by 40% | Properly Billed |
Performance Benchmarking: Neo MD vs Industry Standard
| Performance Metric | Industry Average | Neo MD Pathology |
|---|---|---|
| Clean Claim Rate | 65–75% | 96–98% |
| Denial Rate | 25–35% | 3–5% |
| Molecular Test Coding Accuracy | 58–68% | 97%+ |
| TC/26 Modifier Accuracy | 72–81% | 98%+ |
| LCD Policy Compliance | 78–85% | 99%+ |
| NGS Panel Optimization | 62–74% | 96%+ |
| Days to Payment | 48–68 days | 28–38 days |
| Collection Rate | 89–92% | 97–99% |
Our Process: Revenue Acceleration in 90 Days
Comprehensive pathology-specific analysis:
We perform a comprehensive review of molecular test coding accuracy, assess TC/26 modifier usage, audit LCD policy compliance, evaluate surgical pathology level selection, review flow cytometry coding, analyze NGS panel optimization, and examine ABN documentation. You receive a detailed report that identifies revenue leakage by test category and highlights opportunities for recovery.
Our onboarding process ensures zero disruption to lab operations while seamlessly integrating with LIS systems such as Sunquest, CoPath, PowerPath, and Beaker. We verify all payer enrollments, set up the LCD policy database, and provide staff training on documentation requirements. As a result, most practices submit their first clean claims within 10–12 business days.
Practices experience immediate improvement in molecular test claim acceptance as TC/26 modifier accuracy is optimized and LCD compliance eliminates denials. NGS panel revenue is maximized, previously denied claims are reworked and recovered, and cash flow improvements are visible within 30 days. On average, practices achieve a 26–32% revenue increase by day 90.
We provide bi-weekly LCD policy updates, conduct monthly reviews of the molecular test portfolio, perform quarterly compliance audits, and deliver annual CPT code update training. This proactive approach ensures long-term revenue growth as the molecular test menu expands and coding accuracy improves.
Critical Compliance Issues We Handle
Pathology faces intense regulatory scrutiny. We protect you by managing:
LCD policy compliance
(MAC-specific requirements, constantly updated)
Medical necessity
documentation for molecular tests
ABN requirements
for non-covered tests (patient liability protection)
TC/26 modifier accuracy
prevents payment delays and denials
Reflex testing documentation
when separately billable vs bundled
NGS panel coding rules
tier selection, code stacking
Flow cytometry panel requirements
marker counting, medical necessity
IHC panel justification
appropriate antibody selection documentation
Experimental/investigational determinations
FDA approval vs coverage
Fraud and abuse risk
upcoding, unbundling violations
We keep you compliant, paid, and audit-ready.
Free Download
Pathology Denial Prevention Checklist
The exact pre-submission checklist our coders use for 96%+ clean claim rates.
TC/26 modifier decision tree for all pathology services
NGS panel coding guide (tier selection, code stacking)
IHC panel medical necessity documentation templates
Surgical pathology specimen level selector
Molecular test LCD quick reference by MAC
ABN template for non-covered molecular tests
Flow cytometry coding matrix (marker count, panel selection)
Reflex testing billing rules
Used by 110+ pathology practices. Worth $3,200. Yours free.
Frequently Asked Questions
10-14 days with zero claim disruption. We handle all LIS integration and payer credentialing.
Yes. We work with all major laboratory information systems, including Sunquest, CoPath, PowerPath, Beaker, Epic Beaker, Cerner, and more.
We maintain real-time LCD tracking across all MACs and update coding protocols within 24 hours of policy changes.
6-9% of collections (molecular complexity warrants higher rates), but our clients average 26-32% revenue increase, netting 17-26% more than today.
Yes. We manage send-out test billing including proper ordering of provider documentation and technical requirements.
We provide coverage analysis and billing guidance for new test launches to ensure reimbursement before you invest.
Yes. We assist with the Protecting Access to Medicare Act (PAMA) data collection and submission requirements.
- Financial Attrition Warning
Stop Losing $30K-$70K Every Month
Every month you delay is another month of compounded clinical leakage.
Molecular test denials for LCD violations
TC/26 modifier errors causing payment delays
NGS panels undercoded by 30-40%
IHC panels rejected for missing documentation
Flow cytometry underbilled
ABN compliance gaps creating liability
Surgical pathology levels undercoded
Partner with Neo MD
Operational Performance Protocol
Zero payment delays from modifier errors
Two Ways to Get Started
Option 1
Free Revenue Analysis
No obligation. No sales pitch. Just data.
We’ll show you:
- Molecular test coding accuracy
- TC/26 modifier compliance
- LCD policy violations
- NGS panel optimization opportunities
- Surgical pathology level selection
- Missed revenue by test category
Option 2
Talk to a Specialist
15-minute consultation. Zero pressure.
We’ll discuss:
- Your current billing challenges
- Molecular test denial patterns
- LCD compliance issues
- Whether Neo MD is the right fit
Or call us directly:
- (929) 502-3636
Monday-Friday, 8 am-5 pm EST
Why Cardiology Practices Trust NEO MD
You Get :
Pathology Coding Specialists
not general lab billers
96-98% First-Pass Acceptance
vs 65-75% industry average
97%+ Molecular Test Accuracy
vs 58-68% industry average
98% TC/26 Modifier Accuracy
vs 72-81% standard
99% LCD Policy Compliance
vs 78-85% standard
96% NGS Panel Optimization
vs 62-74% standard
26-32% Revenue Increase
in 90 days
10-14 Day Transition
zero disruption
LIS Integration
all major systems supported
Real-Time LCD Tracking
updated within 24 hours
Molecular Test Portfolio Support
new test launch guidance
90-Day Performance Guarantee
results or we work for free
The Cost of Waiting
If you’re a pathology group collecting $4.2M annually and losing 28% to billing inefficiencies:
$1,176,000
per year in lost revenue
$5.88 million
Over 5 years
That’s expanding your molecular test menu, upgrading equipment, hiring additional pathologists, or building a second lab location.
Every month you wait costs you $98,000 you'll never recover.
The question isn’t “Should I switch?”
The question is: “How much more am I willing to lose?”
Stop the Revenue Bleed
Neo MD Inc. | Pathology Medical Billing Specialists
Maximizing revenue for anatomic and clinical pathology practices nationwide since [YEAR]
Trusted by 95+ pathology groups across all 50 states